DexCom
Medical Devices & Tech
6340 Sequence Dr.
San Diego, CA 92121 USA
phone: 858.200.0200
fax: 858.200.0201
Symbol DXCM
Exchange Nasdaq
Founded 1999
Employees 233
www.dexcom.com
Research Sector Medical Devices & Tech
Summary Description
Continuous glucose monitoring system for diabetic patients
Management
Terrance H. Gregg, President and CEO; Andrew K. Balo, Senior Vice President of Clinical & Regulatory Affairs and Quality Assurance; James H. Brauker, Vice President, Research and Development; Peter Gerhardsson, Vice President of International Business Development; Claudia Graham, Vice President of Marketing; Laura Johnson, Vice President of Intellectual Property; Jeffrey C. Moy, Vice President of Operations; Steven R. Pacelli, Senior Vice President of Corporate Affairs; Jess Roper, Vice President and Chief Financial Officer; Jorge A. Valdes, Senior Vice President of Operations; Richard C. Yang, Vice President of Strategic Affairs
Ownership
Financials Mkt Cap :284


* numbers in thousands

 
Keywords
Diabetes, blood sugar, diabetic, metabolic, insulin, blood, blood tests, glucose, continuous glucose monitoring

Comment | Printable Version | Jul. 01, 2009
If you work for DexCom and want to update this profile, click here

Description
DexCom, Inc., a development stage medical device company, engages in the design and development of continuous glucose monitoring systems for diabetics. The company has developed a short term continuous glucose monitoring system, the DexCom STS System, which includes the STS Sensor, the STS Transmitter, and the STS Receiver.
Products / Services
DexCom is developing two platforms of continuous glucose monitoring, a long term and a short term system.
Technology / Differentiation
The tiny probe-like STS Sensor is inserted by the patient under the skin, and is held in place by an adhesive. Once inserted, the STS Sensor begins continuously monitoring glucose. The STS Transmitter sends the glucose signal from the STS Sensor and wirelessly transmits the data to the hand-held STS Receiver. The STS Receiver processes the glucose signal and with the push of a button, the Receiver displays the patient's current glucose value, as well as 1-hr, 3-hr, and 9-hr trends. The Receiver also sounds an alert when a high or low glucose reading is detected.
Market / Customers
20 million people in the U.S. have diabetes, according to the Center for Disease Control. DexCom's device is designed to help people with diabetes more conveniently and effectively manage their blood sugar levels.
Status
In March 2006, DexCom received FDA approval for its STS Continuous Glucose Monitoring System.


2009-07-03-1278